Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer

GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump

(2019) Georg Schneditz et al.   Science Signaling

Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation

(2018) Leandro Z. Agudelo et al.   Cell Metabolism

Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer

(2018) Yomna Rashad et al.   TUMOR BIOLOGY

Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling

(2018) Wei Wang et al.   OncoTargets and Therapy

Ectopic expression of the chemokine CXCL17 in colon cancer cells

(2016) Lina Ohlsson et al.   BRITISH JOURNAL OF CANCER

The therapeutic potential of orphan GPCRs, GPR35 and GPR55

(2015) Derek M. Shore et al.   Frontiers in Pharmacology

G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease

(2015) Nina Divorty et al.   Frontiers in Pharmacology

Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

(2014) Camilla Böckelman et al.   ACTA ONCOLOGICA

Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17

(2014) José L. Maravillas-Montero et al.   JOURNAL OF IMMUNOLOGY

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer

(2012) L Ohlsson et al.   BRITISH JOURNAL OF CANCER

Tyrphostin analogs are GPR35 agonists

(2011) Huayun Deng et al.   FEBS LETTERS

Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer

(2011) Lina Ohlsson et al.   INTERNATIONAL JOURNAL OF CANCER

Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action

(2010) B. Sitohy et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY